Neural Connections Blog
MD Biosciences insights discussing preclinical research in Pain and Neurodegenerative Conditions
translational research (2)

Promoting Diversity for Translational Success
In preclinical efficacy studies, several factors are often overlooked, and it is important to evaluate variables like sex, age, species,...

The HTX-011 Story
HTX-011 Breakthrough in Pain Management ZYNRELEF, the commercial name for HTX-011, is the first and only FDA-approved extended-release dual-acting...

Wound Healing Models in Pigs
It is important to bridge the gap between lab findings and clinical applications using translational models, ensuring effective translation for human...

Advancing Nerve Injury and Repair Models
Understanding Mechanisms Underlying Neuropathic Pain

Three ways to approach translation
As the general population continues to age, the economic burden of chronic pain and neurodegenerative diseases is increasing and becoming...

The effect of the housing environment and handling on behavior assays
An excerpt from MD Biosciences publication in the Autumn 2022 issue of Göttingen Minipigs Magazine. MD Biosciences operates a neuroscience research...

Pain Studies In Pig: advantages for nerve blocks, local & systemic therapies
MD Biosciences lab has an exclusive expertise in pain studies in the pig. Our scientists have developed an acute model and a neuropathic model in...

MDB Neuropathic Pain Porcine Model Publication Featured in Neurobiology of Pain Journal
MDB Scientists recently published a paper titled “Human-like cutaneous neuropathologies associated with a porcine model of peripheral neuritis: a...